These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9224744)

  • 1. Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas.
    Tse JY; Ng HK; Lau KM; Lo KW; Poon WS; Huang DP
    Hum Pathol; 1997 Jul; 28(7):779-85. PubMed ID: 9224744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
    Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
    Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.
    Cai DX; Banerjee R; Scheithauer BW; Lohse CM; Kleinschmidt-Demasters BK; Perry A
    J Neuropathol Exp Neurol; 2001 Jun; 60(6):628-36. PubMed ID: 11398839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
    Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
    Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.
    Pfisterer WK; Hank NC; Preul MC; Hendricks WP; Pueschel J; Coons SW; Scheck AC
    Neuro Oncol; 2004 Oct; 6(4):290-9. PubMed ID: 15494096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression.
    Simon M; von Deimling A; Larson JJ; Wellenreuther R; Kaskel P; Waha A; Warnick RE; Tew JM; Menon AG
    Cancer Res; 1995 Oct; 55(20):4696-701. PubMed ID: 7553651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characteristics of meningiomas in a cohort of Indian patients: loss of heterozygosity analysis of chromosomes 22, 17, 14 and 10.
    Asirvatham JR; Pai R; Chacko G; Nehru AG; John J; Chacko AG; Muliyil J
    Neurol India; 2013; 61(2):138-43. PubMed ID: 23644312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas.
    Lee JY; Finkelstein S; Hamilton RL; Rekha R; King JT; Omalu B
    Neurosurgery; 2004 Nov; 55(5):1163-73. PubMed ID: 15509323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus.
    Menon AG; Rutter JL; von Sattel JP; Synder H; Murdoch C; Blumenfeld A; Martuza RL; von Deimling A; Gusella JF; Houseal TW
    Oncogene; 1997 Feb; 14(5):611-6. PubMed ID: 9053860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic changes with prognostic value in histologically benign meningiomas.
    Barbera S; San Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Roldan P; Gonzalez-Darder J; Cerda-Nicolas M; Lopez-Gines C
    Clin Neuropathol; 2013; 32(4):311-7. PubMed ID: 23442303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A consistent region of deletion on 1p36 in meningiomas: identification and relation to malignant progression.
    Murakami M; Hashimoto N; Takahashi Y; Hosokawa Y; Inazawa J; Mineura K
    Cancer Genet Cytogenet; 2003 Jan; 140(2):99-106. PubMed ID: 12645646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity on chromosome 22q and 17p correlates with aggressiveness of meningiomas.
    Kim JH; Lee SH; Rhee CH; Park SY; Lee JH
    J Neurooncol; 1998 Nov; 40(2):101-6. PubMed ID: 9892091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation of clinical and chromosomal alterations of benign meningiomas and their recurrences.
    Och W; Szmuda T; Kulbacki K; Witek K; Sikorska B; Zakrzewska M; Springer J; Reszeć J; Parda A; Liberski PP
    Neurol Neurochir Pol; 2016; 50(6):395-402. PubMed ID: 27480481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.
    Rempel SA; Schwechheimer K; Davis RL; Cavenee WK; Rosenblum ML
    Cancer Res; 1993 May; 53(10 Suppl):2386-92. PubMed ID: 8485725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression.
    Lindblom A; Ruttledge M; Collins VP; Nordenskjöld M; Dumanski JP
    Int J Cancer; 1994 Feb; 56(3):354-7. PubMed ID: 8314321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Her2neu amplification associates with Co-deletion 1p/14q in recurrent meningiomas.
    Hamilton BO; Sy JS; Megyesi JF; Ang LC
    Can J Neurol Sci; 2013 May; 40(3):361-5. PubMed ID: 23603172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.